| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
6,925 |
5,559 |
$144K |
| 99213 |
|
9,721 |
7,354 |
$144K |
| 96372 |
|
3,727 |
2,076 |
$22K |
| 87426 |
|
662 |
442 |
$11K |
| 93000 |
|
1,895 |
1,415 |
$10K |
| 87502 |
|
162 |
100 |
$9K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
836 |
635 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
720 |
439 |
$5K |
| 99212 |
|
321 |
189 |
$5K |
| 87635 |
|
138 |
77 |
$4K |
| 99396 |
|
111 |
95 |
$4K |
| 81002 |
|
3,653 |
2,923 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,051 |
801 |
$3K |
| 87637 |
|
126 |
70 |
$3K |
| 82962 |
|
2,388 |
1,809 |
$3K |
| 20610 |
|
144 |
112 |
$3K |
| 90688 |
|
356 |
306 |
$2K |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
904 |
663 |
$2K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,032 |
791 |
$2K |
| 87428 |
|
77 |
53 |
$1K |
| 94760 |
|
2,872 |
2,254 |
$843.39 |
| 90658 |
|
62 |
60 |
$769.88 |
| 93922 |
|
57 |
45 |
$769.64 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
598 |
465 |
$720.82 |
| 99211 |
|
101 |
82 |
$630.84 |
| 99490 |
Ccm add 20min |
240 |
165 |
$578.01 |
| 90471 |
|
161 |
148 |
$546.99 |
| 99497 |
|
12 |
12 |
$530.70 |
| 87804 |
|
25 |
17 |
$520.50 |
| 71046 |
|
65 |
58 |
$432.83 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
80 |
69 |
$403.46 |
| 90662 |
|
299 |
251 |
$395.14 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
140 |
115 |
$263.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
220 |
172 |
$168.77 |
| G0008 |
Administration of influenza virus vaccine |
594 |
505 |
$125.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
956 |
732 |
$118.87 |
| 99406 |
|
57 |
39 |
$117.26 |
| 99397 |
|
146 |
101 |
$105.97 |
| 87210 |
|
39 |
28 |
$90.45 |
| 36415 |
|
119 |
98 |
$84.96 |
| 87220 |
|
36 |
26 |
$75.46 |
| 94640 |
|
13 |
12 |
$67.18 |
| 82270 |
|
107 |
32 |
$55.39 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
156 |
128 |
$47.13 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
37 |
26 |
$30.39 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
44 |
39 |
$28.43 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
502 |
392 |
$0.61 |
| 1159F |
|
199 |
166 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
66 |
57 |
$0.00 |
| 1160F |
|
201 |
168 |
$0.00 |
| 3078F |
|
91 |
77 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
241 |
205 |
$0.00 |
| 3288F |
|
87 |
73 |
$0.00 |
| G9791 |
Most recent tobacco status is tobacco free |
15 |
12 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
23 |
21 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
31 |
27 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
35 |
30 |
$0.00 |
| 1125F |
|
597 |
437 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
83 |
68 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
306 |
262 |
$0.00 |
| 3079F |
|
20 |
16 |
$0.00 |
| 4010F |
|
33 |
26 |
$0.00 |
| 3008F |
|
453 |
369 |
$0.00 |
| 3074F |
|
100 |
82 |
$0.00 |
| 1036F |
|
52 |
45 |
$0.00 |
| 1170F |
|
134 |
110 |
$0.00 |
| 3044F |
|
16 |
14 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
91 |
76 |
$0.00 |
| 1111F |
|
65 |
60 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
52 |
44 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
17 |
13 |
$0.00 |
| 1126F |
|
17 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
59 |
47 |
$0.00 |
| 1101F |
|
49 |
42 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
18 |
14 |
$0.00 |